Literature DB >> 7977368

Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia.

K Kobayashi1, N Shaheen, H Terazono, T Saheki.   

Abstract

Citrullinemia is an autosomal recessive disease caused by a genetic deficiency of argininosuccinate synthetase. In order to characterize mutations in Japanese patients with classical citrullinemia, RNA isolated from 10 unrelated patients was reverse-transcribed, and cDNA amplified by PCR was cloned and sequenced. The 10 mutations identified included 6 missense mutations (A118T, A192V, R272C, G280R, R304W, and R363L), 2 mutations associated with an absence of an exon 7 or exon 13, 1 mutation with a deletion of the first 7 bp in exon 16 (which might be caused by abnormal splicing), and 1 mutation with an insertion of 37 bp within exons 15 and 16 in cDNA. The insertion mutation and the five missense mutations (R304W being excluded) are new mutations described in the present paper. These are in addition to 14 mutations (9 missense mutations, 4 mutations associated with an absence of an exon in mRNA, and 1 splicing mutation) that we identified previously in mainly American patients with neonatal citrullinemia. Two of these 20 mutations, a deletion of exon 13 sequence and a 7-bp deletion in exon 16, were common to Japanese and American populations from different ethnic backgrounds; however, other mutations were unique to each population. Furthermore, the presence of a frequent mutation--the exon 7 deletion mutation in mRNA, which accounts for 10 of 23 affected alleles--was demonstrated in Japanese citrullinemia. This differs from the situation in the United States, where there was far greater heterogeneity of mutations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977368      PMCID: PMC1918437     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Sequences of the genes encoding argininosuccinate synthetase in Escherichia coli and Saccharomyces cerevisiae: comparison with methanogenic archaebacteria and mammals.

Authors:  F Van Vliet; M Crabeel; A Boyen; C Tricot; V Stalon; P Falmagne; Y Nakamura; S Baumberg; N Glansdorff
Journal:  Gene       Date:  1990-10-30       Impact factor: 3.688

2.  A case of citrullinemia with abnormal messenger RNA for argininosuccinate synthetase.

Authors:  O Nukada; C Uchiyama; S Ubuka; T Yoda; K Kobayashi; H Ichiki; T Saheki
Journal:  Acta Paediatr Jpn       Date:  1991-10

3.  Isolation and characterization of argininosuccinate synthetase from human liver.

Authors:  W E O'Brien
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

4.  Analysis of a splice acceptor site mutation which produces multiple splicing abnormalities in the human argininosuccinate synthetase locus.

Authors:  T S Su; L H Lin
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

5.  Molecular characterization of the murine argininosuccinate synthetase locus.

Authors:  L C Surh; A L Beaudet; W E O'Brien
Journal:  Gene       Date:  1991-03-15       Impact factor: 3.688

6.  A search for the primary abnormality in adult-onset type II citrullinemia.

Authors:  K Kobayashi; N Shaheen; R Kumashiro; K Tanikawa; W E O'Brien; A L Beaudet; T Saheki
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

7.  Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.

Authors:  C M Eng; L A Resnick-Silverman; D J Niehaus; K H Astrin; R J Desnick
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

8.  The skipping of constitutive exons in vivo induced by nonsense mutations.

Authors:  H C Dietz; D Valle; C A Francomano; R J Kendzior; R E Pyeritz; G R Cutting
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

9.  Additional mutations in argininosuccinate synthetase causing citrullinemia.

Authors:  K Kobayashi; C Rosenbloom; A L Beaudet; W E O'Brien
Journal:  Mol Biol Med       Date:  1991-02

10.  Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia.

Authors:  T Saheki; A Ueda; M Hosoya; K Kusumi; S Takada; M Tsuda; T Katsunuma
Journal:  Clin Chim Acta       Date:  1981-02-05       Impact factor: 3.786

View more
  5 in total

1.  Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia.

Authors:  T Yasuda; N Yamaguchi; K Kobayashi; I Nishi; H Horinouchi; M A Jalil; M X Li; M Ushikai; M Iijima; I Kondo; T Saheki
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

Review 2.  Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency.

Authors:  Takeyori Saheki; Keiko Kobayashi; Mikio Iijima; Ikumi Nishi; Tomotsugu Yasuda; Naoki Yamaguchi; Hong Zhi Gao; Md Abdul Jalil; Laila Begum; Meng Xian Li
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

3.  Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation.

Authors:  S Ikeda; M Yazaki; Y Takei; T Ikegami; Y Hashikura; S Kawasaki; M Iwai; K Kobayashi; T Saheki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

4.  Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia.

Authors:  K Kobayashi; H Kakinoki; T Fukushige; N Shaheen; H Terazono; T Saheki
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

Review 5.  AGC2 (Citrin) Deficiency-From Recognition of the Disease till Construction of Therapeutic Procedures.

Authors:  Takeyori Saheki; Mitsuaki Moriyama; Aki Funahashi; Eishi Kuroda
Journal:  Biomolecules       Date:  2020-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.